Jasper Therapeutics, Inc. (JSPR) vs Kyntra Bio Inc (KYNB)

Jasper Therapeutics, Inc. and Kyntra Bio Inc are both Biotechnology companies. Jasper Therapeutics, Inc. and Kyntra Bio Inc are of similar size ($14.8M and $14.5M). Jasper Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Kyntra Bio Inc trades at 0.1×. Kyntra Bio Inc has the higher net margin (3,967.8% vs 0.00%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, Kyntra Bio Inc leads on 7 and Jasper Therapeutics, Inc. on 4.

Valuation

Metric JSPR KYNB Biotechnology median
P/E n/m 0.08 11.36
P/S n/m 3.10 9.12
P/B 274.78 n/m 2.14
Price to free cash flow n/m n/m 26.34
EV/EBITDA n/m n/m 0.62
EV/Sales n/m 15.20 8.56
Earnings yield (11.75%) 1,279.66% (34.18%)
Free cash flow yield (15.52%) (265.81%) (23.62%)

Profitability

Metric JSPR KYNB Biotechnology median
Gross margin 0.00% 6.28% 67.24%
Operating margin 0.00% (1,089.78%) 0.00%
Net margin 0.00% 3,967.77% 0.00%
Free cash flow margin 0.00% (824.19%) 0.00%
Return on equity (255.05%) (157.83%) (50.28%)
Return on assets (109.05%) 131.26% (45.89%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric JSPR KYNB Biotechnology median
Revenue growth (TTM) — (37.15%) 6.96%
EPS growth (last fiscal year) 19.22% 478.08% 29.86%
Revenue growth, 5-year CAGR — (48.42%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric JSPR KYNB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.48 2.69 4.72
Net debt to EBITDA 0.35 1.97 1.01

Dividend

Metric JSPR KYNB Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric JSPR KYNB Biotechnology median
Market cap 14.83m 14.54m 167.45m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack